In particular, we could show that IGF2BP1 shields the transcripts of LIN28B and HMGA2 as well as its own mRNA from let-7-mediated downregulation in ovarian cancer-derived cells, thus promoting an aggressive tumor phenotype [20]. This evidence concerns the gene HMGA2 and ovarian carcinoma.